Weitang Yuan

7.6k total citations · 5 hit papers
84 papers, 5.1k citations indexed

About

Weitang Yuan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weitang Yuan has authored 84 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 32 papers in Cancer Research and 29 papers in Oncology. Recurrent topics in Weitang Yuan's work include Cancer-related molecular mechanisms research (24 papers), MicroRNA in disease regulation (16 papers) and Circular RNAs in diseases (16 papers). Weitang Yuan is often cited by papers focused on Cancer-related molecular mechanisms research (24 papers), MicroRNA in disease regulation (16 papers) and Circular RNAs in diseases (16 papers). Weitang Yuan collaborates with scholars based in China, United States and Denmark. Weitang Yuan's co-authors include Zhenqiang Sun, Quanbo Zhou, Guixian Wang, Jinbo Liu, Junmin Song, Chen Chen, Shuaixi Yang, Weiwei Wang, Zhiyong Zhang and Zhenqiang Sun and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Chemical Engineering Journal.

In The Last Decade

Weitang Yuan

78 papers receiving 5.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of exosomal miRNA on cancer biology and clinical applications

2018 625 citations Zhenqiang Sun, Shuaixi Yang et al. Molecular Cancer profile →
Exosomal circRNAs: biogenesis, effect and application in human diseases

2019 504 citations Jinbo Liu, Quanbo Zhou et al. Molecular Cancer profile →
The interplay between m6A RNA methylation and noncoding RNA in cancer

2019 469 citations Shuai Ma, Chen Chen et al. Journal of Hematology & Oncology profile →
Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial

2022 237 citations Weitang Yuan, Taiyuan Li et al. profile →
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers

2023 216 citations Weitang Yuan, Zhenqiang Sun et al. Molecular Cancer profile →

Peers

Countries citing papers authored by Weitang Yuan

Since Specialization

Citations

This map shows the geographic impact of Weitang Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weitang Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weitang Yuan more than expected).

Fields of papers citing papers by Weitang Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weitang Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weitang Yuan. The network helps show where Weitang Yuan may publish in the future.

Co-authorship network of co-authors of Weitang Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Weitang Yuan. A scholar is included among the top collaborators of Weitang Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weitang Yuan. Weitang Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Influence of surgical start time on the quality of surgery for middle and low rectal cancer: a post hoc analysis of the real trial 2025 ·International Journal of Surgery ·Guodong He, (unknown), Weitang Yuan, Taiyuan Li, Bo Tang, Baoqing Jia, Yanbing Zhou, Wei Zhang, Ren Zhao, Cheng Zhang, Longwei Cheng, Xiaoqiao Zhang, Fei Liang, Ye Wei, (unknown), Jianmin Xu	0
2	Breaking the premetastatic niche barrier: the role of endothelial cells and therapeutic strategies 2025 ·Theranostics ·(unknown), Wenming Cui, (unknown), (unknown), (unknown), Zhiyuan Xie, (unknown), Weitang Yuan, Zhen Li, (unknown)	2
3	Neoadjuvant PD-1 blockade in mismatch repair-deficient or microsatellite instability-high, locally advanced and resectable colorectal cancer: A retrospective real-world analysis. 2025 ·Journal of Clinical Oncology ·(unknown), Chang Su, Ruihua Zhao, (unknown), Quanbo Zhou, Shuiling Jin, Shihao Guo, Zhenqiang Sun, (unknown), Guixian Wang, Yang Fu, Yunlong Wang, Weitang Yuan, Xiang‐Bo Wan	0
4	Artificial Intelligence Hybrid Survival Assessment System for Robot-Assisted Proctectomy: A Retrospective Cohort Study 2024 ·JCO Precision Oncology ·Shiqian Zhang, Ge Zhang, (unknown), Song‐Bin Guo, Fuqi Wang, (unknown), Kaisaierjiang Kadier, Zhaokai Zhou, Pengpeng Zhang, Hao Ran, Chuchu Zhang, Quanbo Zhou, Pin Lyu, Shuang Zhao, Shuaixi Yang, Weitang Yuan	6
5	Predictive model of the surgical difficulty of robot-assisted total mesorectal excision for rectal cancer: a multicenter, retrospective study 2024 ·Journal of Robotic Surgery ·Mingyu Han, Shihao Guo, Shuai Ma, Quanbo Zhou, (unknown), Jinbang Wang, Jing Zhuang, Hongwei Yao, Weitang Yuan, (unknown)	1
6	Advances in Engineered Macrophages: A New Frontier in Cancer Immunotherapy 2024 ·Cell Death and Disease ·(unknown), Yuhang Wang, (unknown), (unknown), (unknown), Weitang Yuan, (unknown)	28
7	[Application of preoperative serum CYFRA 21-1 level in the prognosis of colorectal cancer]. 2023 ·PubMed ·Wenqing Hu, Hui Cong, (unknown), Weitang Yuan, (unknown), (unknown), (unknown), Xiaoli Shi	1
8	Effects of RNA methylation on Tumor angiogenesis and cancer progression 2023 ·Molecular Cancer ·Mingyu Han, Haifeng Sun, Quanbo Zhou, Jinbo Liu, Junhong Hu, Weitang Yuan, Zhenqiang Sun	25
9	Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect 2022 ·British Journal of Cancer ·(unknown), (unknown), Yang Liu, Wenkang Wang, (unknown), Weitang Yuan, Zhenqiang Sun, Lin Liu, Chengzeng Wang	52
10	RNA methylation-mediated LINC01559 suppresses colorectal cancer progression by regulating the miR-106b-5p/PTEN axis 2022 ·International Journal of Biological Sciences ·Ke Shi, Shuaixi Yang, Chen Chen, (unknown), Yaxin Guo, Xiaoke Wu, Luyang Zhao, Xiuxiu Yang, Qiuge Zhang, Weitang Yuan, Zhenqiang Sun	19
11	Roles of circRNAs on tumor autophagy 2021 ·Molecular Therapy — Nucleic Acids ·Wenming Cui, Qin Dang, Chen Chen, Weitang Yuan, Zhenqiang Sun	17
12	RNA N6-Methyladenosine in Cancer Metastasis: Roles, Mechanisms, and Applications 2021 ·Frontiers in Oncology ·Qin Dang, Bo Shao, Quanbo Zhou, Chen Chen, Yaxin Guo, Guixian Wang, Jinbo Liu, Quancheng Kan, Weitang Yuan, Zhenqiang Sun	13
13	Exosomal Noncoding RNAs and Tumor Drug Resistance 2020 ·Cancer Research ·(unknown), Jinbo Liu, Quanbo Zhou, Junmin Song, Zhiyong Zhang, Zhen Li, Guixian Wang, Weitang Yuan, Zhenqiang Sun	33
14	CapeOX perioperative chemotherapy versus postoperative chemotherapy for locally advanced resectable colon cancer: protocol for a two-period randomised controlled phase III trial 2019 ·BMJ Open ·Fangqi Liu, Tong Tong, Dan Huang, Weitang Yuan, Dechuan Li, Jianjiang Lin, Sanjun Cai, Ye Xu, Wenbin Chen, Yueming Sun, Jing Zhuang	9
15	The interplay between m6A RNA methylation and noncoding RNA in cancer breakdown → 2019 ·Journal of Hematology & Oncology ·Shuai Ma, Chen Chen, Xiang Ji, Jinbo Liu, Quanbo Zhou, Guixian Wang, Weitang Yuan, Quancheng Kan, Zhenqiang Sun	469
16	Artificial intelligence system of faster region-based convolutional neural network surpassing senior radiologists in evaluation of metastatic lymph nodes of rectal cancer 2019 ·Chinese Medical Journal ·Lei Ding, (unknown), (unknown), Yunpeng Zhou, Shuai Li, Zhengdong Zhang, Yuting Guo, Aiqin Li, Yun Lu, Hongwei Yao, Weitang Yuan, (unknown), (unknown), Lei Wang	36
17	MicroRNAs, long noncoding RNAs, and circular RNAs: potential tumor biomarkers and targets for colorectal cancer 2018 ·Cancer Management and Research ·Shuaixi Yang, Zhenqiang Sun, Quanbo Zhou, Weiwei Wang, Guixian Wang, Junmin Song, Zhen Li, Zhiyong Zhang, Chang Yuan, Kunkun Xia, Jinbo Liu, Weitang Yuan	71
18	LncRNA CPS1-IT1 suppresses EMT and metastasis of colorectal cancer by inhibiting hypoxia-induced autophagy through inactivation of HIF-1α 2017 ·Biochimie ·Wei Zhang, Weitang Yuan, Junmin Song, Shijun Wang, Xiaoming Gu	91
19	The Sensitive Detection of Telomerase Reverse Transcriptase Promoter Mutation by Amplification Refractory Mutation System-PCR 2016 ·Genetic Testing and Molecular Biomarkers ·Jinbo Liu, Zhihua Zhao, Miaomiao Sun, (unknown), Weitang Yuan, Guozhong Jiang	12
20	miR-411 regulated ITCH expression and promoted cell proliferation in human hepatocellular carcinoma cells 2015 ·Biomedicine & Pharmacotherapy ·Kunkun Xia, Yi Zhang, Shengli Cao, Yang Wu, Wenzhi Guo, Weitang Yuan, Shuijun Zhang	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact